Dr. Girdauskas

MVT Aortic 2022, vol.2

Prof. Hermann Reichenspurner

MVT Aortic 2022, vol.2

– This video includes a comprehensive look at aortic valve repair, with topics ranging from repair techniques to remodeling techniques, including challenges, tips and tricks, and outcomes.

– David, Yacoub, Okazi, Ross, reimplantation, remodeling, annuloplasty, and more.

Prof. Jeroen Bax

MVT Aortic 2022, vol.2

– Valve Academic Research Consortium: created in 2010, updated in 2012, and updated again in 2021

– Get up to date regarding clinical endpoints.

– It’s not necessary to memorize it all, but to at least be familiar with all parts of the VARC-3 consensus.

Alexey Dashkevich

MVT Aortic 2022, Vol.2

– Is the patient 50-65 years old? Be sure to think about re-intervention, keep the guidelines in mind, and fully inform the patient.

– Which type of anticoagulation therapy should be used?

– Don’t forget, a Ross procedure may be an option.

Prof. Martin Andreas

MVT Aortic 2022, vol.2

– There are different centers and different techniques, but do they share the same outcomes?

– Be sure to catch his explanation about what makes decellularized heart valves so unique.

– Proper skills and robust training are key.

Prof. Marjan Jahangiri

MVT Aortic 2022, vol.2

– How do we decide between a Ross procedure or a modified Ross procedure? Who are the candidates, and what is their anatomy like?

– Perhaps most interesting, hear what she has to say about how and why we should be cautious when interpreting long-term results, even from large studies and meta-analyses.

– Advantages, disadvantages, complications, autograft failure predictors, and more!

Prof. Ruggero De Paulis

MVT Aortic 2022, vol.2

– Pros and cons of valve-sparing versus the pros and cons of biological or mechanical Bentall procedures

– Plenty of data with plenty of insights, get ready to take notes

– Experience and confidence reign supreme

– If relevant, don’t forget to plan for future valve-in-valve

Dr. Patrick Klein

MVT Aortic 2022, vol.2

– Listen to what he has to say about total aortic root replacement.

– How can we assess the durability and avoid adverse valve-related events when using mechanical and biological valves?

– Hear about his personal experience using new-generation biological valves in patients 57 ± 7 years old.

Dr. Dashkevich

MVT Aortic 2022, vol.2

– For a patient with endocarditis, should we consider a biological or mechanical prosthesis?

– Briefly see an interesting patient case, accompanied by detailed photos and explanations.

– Don’t forget to pay attention to the anterior mitral leaflet, and strongly consider your coronary reimplantation strategy.

Prof. Augusto D’Onofrio

MVT Aortic 2022, vol.1

– Not only about hemodynamics, this lecture provides comparisons among three bioprostheses

– Similar clinical outcomes, better hemodynamic results, and shorter ICU stays for rapid deployment valves… but newer bioprosthesis tissue technology may raise the bar even higher

Prof. Alessandro Della Corte

MVT Aortic 2022, vol.1

– Patients with an “ascending” phenotype? A separate vale and ascending graft replacement procedure is an option

– Patients with a “root” phenotype? Consider addressing the root earlier (50 mm root diameter)

– Bentall is still the gold standard, but valve-sparing procedures have similarly good results

Prof. Ruggero De Paulis

MVT Aortic 2022, vol.1

– First and foremost, not all bicuspid aortic valves are the same

– Many post-operative measurements and goals are included within to help guide you to optimal patient outcomes

– Check out the insight provided about valve-sparing, valve repair, external annuloplasty, and more

Prof. Alessandro Della Corte

MVT Aortic 2022, vol.1

– New classification system and nomenclature of bicuspid aortic valve (and bicuspid aortic valve disease)

– Genes are important, but a single gene may contribute to fewer than 1% of cases

– Different valve repair techniques according to valve phenotype

Prof. Joseph Bavaria

MVT Aortic 2022, vol.1

Prof. Michael Borger

MVT Aortic 2022, vol.1

-The “aortic size paradox”: an interesting paradox, indeed

-Length? Diameter? Which should we pay more attention to?

-Be sure to pay attention to genetics, biomarkers, abnormal flow, other risk factors, and more

Prof. Friedhelm Beyersdorf

MVT Aortic 2022, vol.1

– Guidelines: based on scientific data, not an individual hospital’s, country’s, or region’s practices.

– It’s important to truly understand the recommendations and evidence classifications.

–Pay attention to the details in phrasing.

Prof. Bart Meuris

MVT Aortic 2022, vol.1

• Shorter hospital stays, less anticoagulation, long-term financial savings? Hear about the data of an expert’s personal experience.

• With advanced anti-calcification treatment, the future of bioprostheses is promising not only for patient outcomes, but even from a financial perspective

Dr. Douglas Johnston

STS annual meeting 202

Insights from INDURE registry

Prof. Ruggero De Paulis

Prof. D’Onofrio – EACTS 2021